Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Genertec Universal Medical Group Company Limited

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Financial - Credit ServicesSector: Financial Services

Fair Value Summary

Current Price$6.24
5Y Range116.21 – 282.59
5Y Selected199.40
(-) Safety Margin33.35%
5Y Buy Price$138.92
Upside (to Buy Price)2,126.31%
10Y Range133.49 – 316.10
10Y Selected224.79
(-) Safety Margin33.35%
10Y Buy Price$156.61
Upside (to Buy Price)2,409.84%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9469
Revenue R2 (10Y)0.9760
Net Income R2 (5Y)0.8742
Net Income R2 (10Y)0.9507
EBITDA R2 (5Y)0.9683
EBITDA R2 (10Y)0.9260
FCF R2 (5Y)0.3072
FCF R2 (10Y)0.6222
Safety Score0.6967

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth10.44%9.72%9.01%8.29%7.58%6.86%6.15%5.43%4.72%4.00%
Revenue15,089.8716,557.1918,048.7319,545.5021,026.5422,469.3723,850.4525,145.7626,331.5027,384.76
EBITDA13,809.9415,152.8116,517.8317,887.6419,243.0720,563.5221,827.4523,012.8924,098.0625,061.98
D&A-471.30-517.13-563.72-610.47-656.72-701.79-744.92-785.38-822.41-855.31
EBIT13,338.6414,635.6715,954.1217,277.1818,586.3519,861.7321,082.5222,227.5123,275.6524,206.67
Pro forma Taxes-3,279.60-3,598.51-3,922.68-4,247.98-4,569.87-4,883.45-5,183.61-5,465.13-5,722.84-5,951.75
NOPAT10,059.0411,037.1712,031.4413,029.2014,016.4814,978.2815,898.9116,762.3817,552.8118,254.92
Capital Expenditures-761.91-835.99-911.30-986.88-1,061.66-1,134.51-1,204.24-1,269.64-1,329.51-1,382.69
NWC Investment-937.71-964.62-980.54-983.98-973.64-948.52-907.92-851.54-779.51-692.42
(+) D&A471.30517.13563.72610.47656.72701.79744.92785.38822.41855.31
Free Cash Flow8,830.739,753.6810,703.3111,668.8112,637.9013,597.0414,531.6815,426.5816,266.2017,035.12
Diluted Shares Outstanding2,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.502,026,137,787.50

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start6/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point9/30/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 6.60%Terminal Growth: 3.11%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.910.850.800.750.710.660.620.58
PV UFCF8,774.469,471.069,749.629,970.9210,130.3110,224.2510,250.4310,207.8710,096.979,919.49
Raw: 373,286.61
289,807.68
Raw: 503,167.74
283,776.60

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value337,904.05382,571.99
(-) Net Debt6,320.466,320.46
Equity Value331,583.59376,251.53
(/) Shares Out2,026.142,026.14
Fair Value$163.65$185.70
(-) Safety Margin33.35%33.35%
Buy Price$109.07$123.77
Current Price$6.24$6.24
Upside (to Buy Price)1,647.99%1,883.47%

Conservative Projected Flows

WACC: 7.60%Terminal Growth: 2.61%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.900.840.780.720.670.620.580.54
PV UFCF8,766.279,430.479,617.619,744.509,808.279,807.229,740.969,610.369,417.609,166.09
Raw: 259,829.60
194,400.85
Raw: 350,234.56
181,672.71

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value241,767.98276,782.07
(-) Net Debt6,320.466,320.46
Equity Value235,447.52270,461.61
(/) Shares Out2,026.142,026.14
Fair Value$116.21$133.49
(-) Safety Margin33.35%33.35%
Buy Price$77.45$88.97
Current Price$6.24$6.24
Upside (to Buy Price)1,141.20%1,325.78%

Aggressive Projected Flows

WACC: 5.60%Terminal Growth: 3.61%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.980.920.870.830.780.740.700.670.63
PV UFCF8,782.739,512.229,884.7110,204.8010,466.1110,663.2010,791.7410,848.7010,832.4510,742.82
Raw: 657,709.85
530,043.00
Raw: 886,553.04
544,056.58

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value578,893.57646,786.05
(-) Net Debt6,320.466,320.46
Equity Value572,573.11640,465.59
(/) Shares Out2,026.142,026.14
Fair Value$282.59$316.10
(-) Safety Margin33.35%33.35%
Buy Price$188.35$210.68
Current Price$6.24$6.24
Upside (to Buy Price)2,918.41%3,276.31%

Reverse DCF: Market Implied Growth

Current Price$6.24
WACC Used6.6%
IMPLIED REVENUE GROWTH86.25%
Metric2027202820292030203120322033203420352036
Implied Revenue51,638.7096,176.45179,127.46333,622.71621,368.221,157,290.722,155,439.844,014,480.407,476,920.7413,925,673.61
Constant Implied Growth86.25%86.25%86.25%86.25%86.25%86.25%86.25%86.25%86.25%86.25%
Implied Free Cash Flow5.169.6217.9133.3662.14115.73215.54401.45747.691,392.57
Discount Factor0.960.850.800.750.710.660.620.580.550.51
Present Value of Implied FCF4.948.2214.3625.0943.8376.58133.80233.76408.42713.57

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$5.2711.11%$-50.19-1,052.37%
20182018-12-31$5.1411.43%$-101.36-2,072.02%
20172017-12-31$6.4218.32%$-111.72-1,840.14%
20162016-12-31$5.7423.94%$-67.81-1,281.42%
20152015-12-31$5.0129.04%$-156.59-3,225.49%
20142014-12-31$3.9924.16%$-198.19-5,067.22%
20132013-12-31$3.9010.39%$-79.55-2,139.66%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$212.01
Median
$184.33
10th Percentile
$133.60
90th Percentile
$314.61

Fair Value Distribution

$95.56 - $174.84
434
$174.84 - $254.11
382
$254.11 - $333.39
104
$333.39 - $412.67
42
$412.67 - $491.95
13
$491.95 - $571.22
10
$571.22 - $650.50
6
$650.50 - $729.78
4
$729.78 - $809.05
1
$809.05 - $888.33
0
$888.33 - $967.61
1
$967.61 - $1,046.89
2
$1,046.89 - $1,126.16
0
$1,126.16 - $1,205.44
0
$1,205.44 - $1,284.72
0
$1,284.72 - $1,364.00
0
$1,364.00 - $1,443.27
0
$1,443.27 - $1,522.55
0
$1,522.55 - $1,601.83
0
$1,601.83 - $1,681.10
1